FY25 Full Year Results and Strategy Update

Dr. Martens plc released its FY25 Full Year Results presentation and a Strategy update presentation on Thursday 5th June. Please watch the events using the links below.

Share price (LSE: DOCS)

Read more

Regulatory news

Read more

Investors_WhyInvest.png

Why invest

We have a number of competitive strengths which act as differentiators and position the business for growth.

Investment case

>65

years of heritage

65%

Revenue from DTC

£787.6m

Revenue

£34.1m

Adjusted PBT

10.5

million pairs sold

60+

countries operated in

£37.0m

EBIT

Results centre

4.7%

EBIT margin

Source: DM Audited Accounts, Company data.
Note: March financial year end. All figures are FY25, unless otherwise specified.